Novo Nordisk shares jump 5% as drugmaker sees copycat Wegovy sales easing in 2025 – CNBC
Business News
- Novo Nordisk shares jump 5% as drugmaker sees copycat Wegovy sales easing in 2025 CNBC
- Obesity drugmaker Novo Nordisk cuts 2025 outlook, posts Q1 profit above forecast Yahoo Finance
- Novo Nordisk shares up on hopes for US Wegovy recovery after forecasts cut Reuters
- Novo Nordisk Cuts Guidance as Copycat Versions of Ozempic Hit Sales WSJ
- Novo Nordisk shares are rising after the company cut its outlook. It’s been that kind of year. MarketWatch
Source: Business News